Abstract
Twenty-three patients with malignant central nervous system tumors were treated with fludarabine phosphate (2-FAMP) on a 5 day bolus schedule. One brief partial response was observed in 20 malignant astrocytoma patients. 2FAMP as given in this protocol is inactive in previously treated patients with recurrent malignant astrocytomas.
Original language | English (US) |
---|---|
Pages (from-to) | 195-197 |
Number of pages | 3 |
Journal | Investigational New Drugs |
Volume | 9 |
Issue number | 2 |
DOIs | |
State | Published - May 1991 |
Keywords
- central nervous system tumors
- fludarabine phosphate
- phase II
ASJC Scopus subject areas
- Oncology
- Pharmacology
- Pharmacology (medical)